K. H. Grabstein, J. Eisenman, and K. Shanebeck, Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor, Science, vol.264, p.965, 1994.

W. E. Carson, J. G. Giri, and M. J. Lindemann, Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor, J Exp Med, vol.180, p.1395, 1994.

X. Zhang, S. Sun, I. Hwang, D. F. Tough, and J. Sprent, Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15, Immunity, vol.8, p.591, 1998.

M. K. Kennedy, M. Glaccum, and S. N. Brown, Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice, J Exp Med, vol.191, p.771, 2000.

J. G. Giri, M. Ahdieh, and J. Eisenman, Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15, EMBO J, vol.13, p.2822, 1994.

D. M. Anderson, S. Kumaki, and M. Ahdieh, Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes, J Biol Chem, vol.270, p.29862, 1995.

A. Ma, R. Koka, and P. Burkett, Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis, Annu Rev Immunol, vol.24, p.657, 2006.

W. J. Leonard, Role of Jak kinases and STATs in cytokine signal transduction, Int J Hematol, vol.73, p.271, 2001.

A. E. Hunt, F. V. Lali, and J. D. Lord, Role of interleukin (IL)-2 receptor b-chain subdomains and Shc in p38 mitogen-activated protein (MAP) kinase and p54 MAP kinase (stress-activated protein kinase/c-Jun N-terminal kinase) activation. IL-2-driven proliferation is independent of p38 and p54 MAP kinase activation, J Biol Chem, vol.274, p.7591, 1999.

H. Gu, H. Maeda, and J. J. Moon, New role for Shc in activation of the phosphatidylinositol-3-kinase/Akt pathway, Mol Cell Biol, vol.20, p.7109, 2000.

S. Bulfone-paus, E. Bulanova, and T. Pohl, Death deflected: IL-15 inhibits TNF-a-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ra chain, FASEB J, vol.13, p.1575, 1999.

E. Bulanova, V. Budagian, and T. Pohl, The IL-15R alpha chain signals through association with Syk in human B cells, J Immunol, vol.167, p.6292, 2001.

S. Dubois, J. Mariner, T. A. Waldmann, and Y. Tagaya, IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells, Immunity, vol.17, p.537, 2002.

P. R. Burkett, R. Koka, M. Chien, S. Chai, D. L. Boone et al., Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis, J Exp Med, vol.200, pp.825-859, 2004.

E. Mortier, R. Advincula, and L. Kim, Macrophage-and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets, Immunity, vol.31, pp.811-833, 2009.

H. Kobayashi, S. Dubois, and N. Sato, Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance, Blood, vol.105, pp.721-728, 2005.

E. Mortier, J. Bernard, A. Plet, and Y. Jacques, Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist, J Immunol, vol.173, p.1681, 2004.

M. P. Rubinstein, M. Kovar, and J. F. Purton, Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}, Proc Natl Acad Sci, vol.103, p.9166, 2006.

T. A. Stoklasek, K. S. Schluns, and L. Lefrançois, Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo, J Immunol, vol.177, p.6072, 2006.

E. Mortier, A. Quéméner, and P. Vusio, Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15×IL-15R alpha fusion proteins, J Biol Chem, vol.281, p.1612, 2006.

G. Bouchaud, L. Garrigue-antar, and V. Solé, The exon-3-encoded domain of IL-15ralpha contributes to IL-15 highaffinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha, J Mol Biol, vol.382, p.1, 2008.

T. Walzer, L. Chiossone, and J. Chaix, Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor, Nat Immunol, vol.8, p.1337, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00297257

N. D. Huntington, N. Legrand, and N. L. Alves, IL-15 transpresentation promotes human NK cell development and differentiation in vivo, J Exp Med, vol.206, p.25, 2009.

A. Bessard, V. Solé, G. Bouchaud, A. Quéméner, and Y. Jacques, High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor alpha fusion protein, in metastatic melanoma and colorectal cancer, Mol Cancer Ther, vol.8, p.2736, 2009.

T. Hori, T. Uchiyama, and M. Tsudo, Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus, Blood, vol.70, p.1069, 1987.

J. Bernard, C. Harb, and E. Mortier, Identification of an interleukin-15 alpha receptor binding site on human interleukin-15, J Biol Chem, vol.279, p.24313, 2004.

P. Lehours, S. Raher, S. Dubois, J. Guo, A. Godard et al., Subunit structure of the high and low affinity human interleukin-15 receptors, Eur Cytokine Network, vol.11, p.207, 2000.

G. H. Cornish, L. V. Sinclair, and D. A. Cantrell, Differential regulation of T-cell growth by IL-2 and IL-15, Blood, vol.108, p.600, 2006.

S. Kumaki, R. Armitage, M. Ahdieh, L. Park, and D. Cosman, Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high-affinity binding sites on human T and B cells, Eur J Immunol, vol.26, p.1235, 1996.

G. Vámosi, A. Bodnár, and G. Vereb, IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells, Proc Natl Acad Sci, vol.101, p.11082, 2004.

T. Rose, A. H. Pillet, and V. Lavergne, Interleukin-7 compartmentalizes its receptor signaling complex to initiate CD4 T lymphocyte response, J Biol Chem, vol.285, p.14898, 2010.

T. Miyazaki, A. Kawahara, and H. Fujii, Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits, Science, vol.266, p.1045, 1994.

J. X. Lin, T. S. Migone, and M. Tsang, The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15, Immunity, vol.2, p.331, 1995.

E. Zambricki, A. Shigeoka, and H. Kishimoto, Signaling T-cell survival and death by IL-2 and IL-15, Am J Transplant, vol.5, p.2623, 2005.

N. Sato, H. J. Patel, T. A. Waldmann, and Y. Tagaya, The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells, Proc Natl Acad Sci, vol.104, p.588, 2007.

E. Mortier, T. Woo, R. Advincula, S. Gozalo, and A. Ma, IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation, J Exp Med, vol.205, p.1213, 2008.

T. A. Waldmann, Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases, Arthritis Res Ther, vol.6, p.174, 2004.

M. A. Silva, J. Menezes, C. Deslandres, and E. G. Seidman, Antiinflammatory role of interleukin-15 in Crohn's disease, Inflamm Bowel Dis, vol.11, p.219, 2005.

G. Bouchaud, E. Mortier, and M. Flamant, Interleukin-15 and its soluble receptor (sIL-15Ralpha) mediate the response to infliximab in patients with Crohn's disease, Gastroenterology, 2010.

K. S. Schluns, T. Stoklasek, and L. Lefrancois, The roles of interleukin-15 receptor alpha: transpresentation, receptor component, or both?, Int J Biochem Cell Biol, vol.37, p.1567, 2005.

S. K. Olsen, N. Ota, and S. Kishishita, Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation, J Biol Chem, vol.282, p.37191, 2007.

S. W. Stonier and K. S. Schluns, Trans-presentation: a novel mechanism regulating IL-15 delivery and responses, Immunol Lett, vol.127, p.85, 2010.

A. H. Pillet, F. Bugault, J. Thèze, L. A. Chakrabarti, and T. Rose, A programmed switch from IL-15-to IL-2-dependent activation in human NK cells, J Immunol, vol.82, p.6267, 2009.

C. Badoual, G. Bouchaud, A. Nel, and H. , The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer, Cancer Res, vol.68, p.3907, 2008.

V. Budagian, E. Bulanova, and Z. Orinska, Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ ADAM17), J Biol Chem, vol.279, p.40368, 2004.

E. Bulanova, V. Budagian, and E. Duitman, Soluble Interleukin IL-15Ralpha is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15, J Biol Chem, vol.282, p.13167, 2007.

J. Scheller, N. Ohnesorge, R. , and S. , Interleukin-6 transsignalling in chronic inflammation and cancer, Scand J Immunol, vol.63, p.321, 2006.

R. Scheller, J. Elson, G. Jones, and S. A. , Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer, J Leukoc Biol, vol.80, p.227, 2006.